Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1445

Nov 10, 2020

Concurrent sharing of an avatar body

Posted by in categories: biotech/medical, internet, robotics/AI, virtual reality

The COVID-19 crisis has led to a significant increase in the use of cyberspace, enabling people to work together at distant places and interact with remote environments and individuals by embodying virtual avatars or real avatars such as robots. However, the limits of avatar embodiment are not clear. Furthermore, it is not clear how these embodiments affect the behaviors of humans.

Therefore, a research team comprising Takayoshi Hagiwara () and Professor Michiteru Kitazaki from Toyohashi University of Technology; Dr. Ganesh Gowrishankar (senior researcher) from UM-CNRS LIRMM; Professor Maki Sugimoto from Keio University; and Professor Masahiko Inami from The University of Tokyo aimed to develop a novel collaboration method with a shared avatar, which can be controlled concurrently by two individuals in VR, and to investigate human motor behaviors as the avatar is controlled in VR.

Full movements of two participants were monitored via a motion-capture system, and movements of the shared avatar were determined as the average of the movements of the two participants. Twenty participants (10 dyads) were asked to perform reaching movements with their towards target cubes that were presented at various locations. Participants exhibited superior reaction times with the shared avatar than individual reaction times, and the avatar’s hand movements were straighter and less jerky than those of the participants. The participants exhibited a sense of agency and body ownership towards the shared avatar although they only formed a part of the shared avatar.

Nov 10, 2020

Safeguard That Protects Blood’s ‘Fountain of Youth’ Discovered

Posted by in categories: biotech/medical, life extension

Summary: YTHDF2 is a key protein that assists in creating healthy blood cells by regulating the body’s inflammatory response.

Source: University of Edinburgh

The study is the first to reveal a protein that has a crucial role in protecting the blood’s stem cells, which continually produce all blood and immune cells needed in the body, from premature aging.

Nov 10, 2020

Two genes regulate social dominance

Posted by in categories: biotech/medical, chemistry

Rank in social hierarchy is a condition not solely claimed by humans. In the animal kingdom, male peacocks exhibit brightly colored plumes to illustrate dominance, and underwater, male fish show pops of bright colors to do the same. Despite the links identified between social status, physiology and behavior, the molecular basis of social status has not been known, until now.

“We discovered that two paralogous androgen receptor genes control social status in African cichlid fish,” reports Beau Alward in the Proceedings of the National Academy of Sciences. Alward is an assistant professor of psychology at the University of Houston with a joint appointment in biology and biochemistry. Paralogs are duplicate genes; androgens are hormones like testosterone necessary for male sexual development.

“Testosterone binds to to exert its effects. What we found through genome editing is that the two genes encoding these receptors are required for different aspects of social status,” said Alward. “This type of coordination of social status may be fundamental across species that rely on social information to optimally guide physiology and behavior.”

Nov 10, 2020

Four Quick Stories on Press Freedoms and Venture Funding: Age of Ingenuity

Posted by in categories: biotech/medical, government, military

https://www.youtube.com/watch?v=wb7o_9CUmiM&feature=youtu.be

Remember to like, comment, share and subscribe to support this vidcast.

Sources cited in this episode include the following:

Continue reading “Four Quick Stories on Press Freedoms and Venture Funding: Age of Ingenuity” »

Nov 10, 2020

Genetic disposition protects immune system from aging

Posted by in categories: biotech/medical, genetics, life extension

A genetic disposition that plays a role in the development of the heart in the embryo also appears to play a key role in the human immune system. This is shown by a recent study led by the University of Bonn (Germany). When the gene is not active enough, the immune defense system undergoes characteristic changes, causing it to lose its effectiveness. Doctors speak of an aging immune system, as a similar effect can often be observed in older people. In the medium term, the results may contribute to reduce these age-related losses. The study is published in the journal Nature Immunology.

The gene with the cryptic abbreviation CRELD1 has so far been a mystery to science. It was known to play an important role in the development of the heart in the embryo. However, CRELD1 remains active after birth: Studies show that it is regularly produced in practically all of the body. For what purpose, however, was previously completely unknown.

The Bonn researchers used a novel approach to answer this question. Nowadays, scientific studies with often include so-called transcriptome analyses. By these means, one can determine which genes are active to what extent in the respective test subjects. Researchers are also increasingly making the data they obtain available to colleagues, who can then use it to work on completely different matters. “And this is exactly what we did in our study,” says Dr. Anna Aschenbrenner from the LIMES Institute at the University of Bonn and member of the ImmunoSensation² Cluster of Excellence.

Nov 10, 2020

Marine Fungi: A Source of Potential Anticancer Compounds

Posted by in categories: biotech/medical, chemistry

Metabolites from marine fungi have hogged the limelight in drug discovery because of their promise as therapeutic agents. A number of metabolites related to marine fungi have been discovered from various sources which are known to possess a range of activities as antibacterial, antiviral and anticancer agents. Although, over a thousand marine fungi based metabolites have already been reported, none of them have reached the market yet which could partly be related to non-comprehensive screening approaches and lack of sustained lead optimization. The origin of these marine fungal metabolites is varied as their habitats have been reported from various sources such as sponge, algae, mangrove derived fungi, and fungi from bottom sediments. The importance of these natural compounds is based on their cytotoxicity and related activities that emanate from the diversity in their chemical structures and functional groups present on them. This review covers the majority of anticancer compounds isolated from marine fungi during 2012–2016 against specific cancer cell lines.

Marine fungi are important source of secondary metabolites useful for the drug discovery purposes. Even though marine fungi are less explored in comparison to their terrestrial counterparts, a number of useful hits have been obtained from the drug discovery perspective adding to their importance in the natural product discovery (Molinski et al., 2009; Butler et al., 2014), which have yielded a wide range of chemically diverse agents with antibacterial, antiviral and anticancer properties in animal systems. Starting with the celebrated example of cephalosporins, marine fungi have provided unique chemical skeletons that could be used to develop drugs of clinical importance (Bhadury et al., 2006; Saleem et al., 2007; Javed et al., 2011; Sithranga and Kathiresan, 2011). Fungi, in general, have been generous source of drugs as evidenced by the isolation of many drugs in use such as paclitaxel, camptothecin, vincristine, torreyanic acid and cytarabine to name a few.

Nov 10, 2020

#53 the Longevity Dialogues: Selling the science, with Aubrey de Grey, Nir Barzilai & Keith Comito

Posted by in categories: biotech/medical, life extension, science

Host Mark Sackler and panelists discuss the challenges of getting governments and the public on board with one of the basic principles of longevity research: that the cause of all chronic diseases of aging is aging itself.

Nov 10, 2020

Making 3D nanosuperconductors with DNA

Posted by in categories: biotech/medical, chemistry, computing, engineering, nanotechnology, quantum physics

Three-dimensional (3D) nanostructured materials—those with complex shapes at a size scale of billionths of a meter—that can conduct electricity without resistance could be used in a range of quantum devices. For example, such 3D superconducting nanostructures could find application in signal amplifiers to enhance the speed and accuracy of quantum computers and ultrasensitive magnetic field sensors for medical imaging and subsurface geology mapping. However, traditional fabrication tools such as lithography have been limited to 1-D and 2-D nanostructures like superconducting wires and thin films.

Now, scientists from the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory, Columbia University, and Bar-Ilan University in Israel have developed a platform for making 3D superconducting nano-architectures with a prescribed organization. As reported in the Nov. 10 issue of Nature Communications, this platform is based on the self-assembly of DNA into desired 3D shapes at the nanoscale. In DNA self-assembly, a single long strand of DNA is folded by shorter complementary “staple” strands at specific locations—similar to origami, the Japanese art of paper folding.

“Because of its structural programmability, DNA can provide an assembly platform for building designed nanostructures,” said co-corresponding author Oleg Gang, leader of the Soft and Bio Nanomaterials Group at Brookhaven Lab’s Center for Functional Nanomaterials (CFN) and a professor of chemical engineering and of applied physics and at Columbia Engineering. “However, the fragility of DNA makes it seem unsuitable for functional device fabrication and nanomanufacturing that requires inorganic materials. In this study, we showed how DNA can serve as a scaffold for building 3D nanoscale architectures that can be fully “converted” into inorganic materials like superconductors.”

Nov 10, 2020

Exponential Wisdom Episode 93: Longevity Mindset: Part 3

Posted by in categories: biotech/medical, life extension

Peter and Dan continue their conversation about the Abundance Platinum Longevity trip, where Peter and a select group of entrepreneurs, executives and investors spent five days learning from the top longevity and immunology experts in two of California’s top biotech hubs.

To hear past episodes: http://podcast.diamandis.com or Subscribe on Apple Podcasts: https://podcasts.apple.com/us/podcast/exponential-wisdom/id1001794471
Subscribe on Spotify: https://open.spotify.com/show/4kndtSutHbCBQNaDmdV1fU

Nov 9, 2020

Study sets the first germanium-based constraints on dark matter

Posted by in categories: biotech/medical, futurism

Cosmological observations and measurements collected in the past suggest that ordinary matter, which includes stars, galaxies, the human body and countless other objects/living organisms, only makes up 20% of the total mass of the universe. The remaining mass has been theorized to consist of so-called dark matter, a type of matter that does not absorb, reflect or emit light and can thus only be indirectly observed through gravitational effects on its surrounding environment.

While the exact nature of this elusive type of matter is still unknown, in recent decades, physicists have identified many particles that reach beyond the standard model (the theory describing some of the main physical forces in the universe) and that could be good candidates. They then tried to detect these particles using two main types of advanced particle detector: gram-scale semiconducting detectors (usually made of silicon and used to search for low-mass dark matter) and ton-scale gaseous detectors (which have higher energy detection thresholds and are better suited to perform high-mass dark matter searches).

The EDELWEISS Collaboration, a large group of researchers working at Université Lyon 1, Université Paris-Saclay and other institutes in Europe, recently carried out the first search for Sub-MeV dark matter using a germanium(Ge)-based detector. While the team was unable to detect dark matter, they set a number of constraints that could inform future investigations.